ShockWave Medical (SWAV)
(Real Time Quote from BATS)
$329.96 USD
+0.11 (0.03%)
Updated May 21, 2024 10:57 AM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Balance Sheet
Fiscal Year End for ShockWave Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 991 | 305 | 201 | 202 | 195 |
Receivables | 115 | 71 | 37 | 12 | 7 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 108 | 75 | 43 | 30 | 12 |
Other Current Assets | 13 | 8 | 5 | 2 | 2 |
Total Current Assets | 1,225 | 459 | 286 | 246 | 217 |
Net Property & Equipment | 69 | 48 | 24 | 16 | 5 |
Investments & Advances | 2 | 4 | 6 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 99 | 98 | 0 | 0 | 0 |
Intangibles | 132 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 9 | 5 | 2 | 2 | 2 |
Total Assets | 1,567 | 646 | 346 | 272 | 232 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 6 | 3 | 7 |
Accounts Payable | 9 | 7 | 4 | 1 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 92 | 55 | 41 | 20 | 14 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 104 | 63 | 52 | 26 | 24 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 4 | 0 | 0 | 0 | 0 |
Convertible Debt | 732 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 24 | 12 | 13 | 7 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 23 | 12 | 12 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 898 | 135 | 104 | 46 | 39 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 558 | 549 | 495 | 469 | 371 |
Retained Earnings | 110 | -37 | -253 | -244 | -178 |
Other Equity | 0 | -1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 669 | 511 | 242 | 226 | 193 |
Total Liabilities & Shareholder's Equity | 1,567 | 646 | 346 | 272 | 232 |
Total Common Equity | 669 | 511 | 242 | 226 | 193 |
Shares Outstanding | 36.90 | 36.10 | 35.30 | 34.20 | 28.30 |
Book Value Per Share | 18.12 | 14.16 | 6.85 | 6.60 | 6.81 |
Fiscal Year End for ShockWave Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,029 | 991 | 917 | 259 | 417 |
Receivables | 124 | 115 | 99 | 97 | 84 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 111 | 108 | 97 | 92 | 83 |
Other Current Assets | 10 | 13 | 15 | 9 | 6 |
Total Current Assets | 1,275 | 1,225 | 1,129 | 456 | 591 |
Net Property & Equipment | 79 | 69 | 62 | 60 | 54 |
Investments & Advances | 2 | 2 | 2 | 3 | 3 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 112 | 99 | 109 | 95 | 98 |
Intangibles | 132 | 132 | 134 | 134 | 0 |
Deposits & Other Assets | 9 | 9 | 8 | 8 | 6 |
Total Assets | 1,644 | 1,567 | 1,474 | 787 | 783 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 10 | 9 | 7 | 13 | 11 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 80 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 79 | 92 | 70 | 66 | 50 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 92 | 104 | 78 | 80 | 142 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 4 | 4 | 10 | 10 | 0 |
Convertible Debt | 733 | 732 | 731 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 24 | 24 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 23 | 22 | 22 | 12 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 892 | 898 | 873 | 170 | 213 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 586 | 558 | 535 | 586 | 569 |
Retained Earnings | 166 | 110 | 66 | 31 | 2 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 752 | 669 | 601 | 617 | 571 |
Total Liabilities & Shareholder's Equity | 1,644 | 1,567 | 1,474 | 787 | 783 |
Total Common Equity | 752 | 669 | 601 | 617 | 571 |
Shares Outstanding | 37.50 | 36.90 | 36.70 | 36.60 | 36.50 |
Book Value Per Share | 20.05 | 18.12 | 16.38 | 16.86 | 15.64 |